Drawing for TARGETINGONE

USPTO serial 79343943

TARGETINGONE

Reviewed by CopyMark Law Group

Reg. 7601773Status 700Registered
Filing date
Status date
Registration date
Dec 17, 2024
Examiner
CORDOVA, RAUL
Law office
FILE REPOSITORY (FRANCONIA)

What this means

Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with TARGETINGONE?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

NAZLY AILEEN BAYRAMOGLU

NAZLY AILEEN BAYRAMOGLU BAYRAMOGLU LAW OFFICES LLC1540 WEST WARM SPRINGS ROADSUITE 100HENDERSON, NV 89014

Goods and services

ClassDescriptionStatusFirst use
005Chemical reagents for medical or veterinary purposes; diagnostic biomarker reagents for medical purposes; chemical reagents used for rapid extraction of nucleic acids from biological samples; diagnostic kits comprised of medical diagnostic reagents and assays for testing of bodily fluids for use in disease detection, namely, for detecting and treating infectious diseases, hereditary diseases, leukemia, and cancer; diagnostic preparations for medical purposes for detecting the presence of malignant, inflammatory and autoimmune disorders and conditions; medical diagnostic test strips for blood analysis, urine analysis, saliva analysis; salts for medical purposes; preparations of microorganisms for medical purposes; biological preparations for the treatment of cancer; diagnostic preparations for medical purposesACTIVE—
009Measuring apparatus, namely, electronic devices used for the qualitative measurement of virus neutralizing antibodies in human serum, plasma and whole blood for laboratory or research purposes; scientific apparatus, namely, polymerase chain reaction (PCR) analyzer for measuring relative DNA, RNA and protein; scientific apparatus and instruments for measuring relative DNA, RNA and protein and parts and fittings therefor; surveying apparatus; surveying instruments; precision measuring apparatus, namely, electronic devices used for the qualitative measurement of virus neutralizing antibodies in human serum, plasma and whole blood for laboratory or research purposes; measuring instruments, namely, electronic devices used for the qualitative measurement of virus neutralizing antibodies in human serum, plasma and whole blood for laboratory or research purposes; computer software applications, downloadable, for use in medical diagnostic fields; downloadable computer software for application and database integration; diagnostic apparatus for the detection of pathogens for laboratory or research use; medical laboratory research instruments for detecting pathogens and DNA analysis; optical inspection apparatus; sample preparation devices for laboratory or research purposes; scientific apparatus and instruments for extracting, purifying and separating nucleic acid for laboratory or research purposes; technical measuring and testing apparatus and instruments for measuring, testing and checking the temperature, pressure, quantity and concentration of gas and liquids; polymerase chain reaction (PCR) testing apparatus for laboratory or research purposeACTIVE—
010Medical apparatus and instrument for diagnostic use, namely, apparatus for medical diagnostic testing in the fields of cancer or other tissue-based diagnostic testing, cytology and cell-based testing; sample preparation device for medical diagnostic use; medical apparatus used for rapid extraction, purification and separation of nucleic acid from samples; polymerase chain reaction (PCR) analyzing apparatus for medical purposes; medical diagnostic instruments for the analysis of body fluids; polymerase chain reaction (PCR) testing apparatus for medical purposes; immunochemical medical diagnostic testing apparatus for detecting and measuring antibody levels; blood testing apparatus; inhalers for medical use; insufflators for medical use; cases fitted for medical instruments; surgical apparatus and instruments; probes for medical purposes; medical diagnostic apparatus for testing DNA and RNA samples; medical diagnostic apparatus for testing for viruses; medical diagnostic apparatus for detecting cancer; medical diagnostic apparatus for testing cancer cells and DNA, incorporating recorded operating system softwareACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Feb 12, 2026NREPNEW REPRESENTATIVE AT IB RECEIVED—
Jun 6, 2025FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
May 19, 2025FICSFINAL DISPOSITION NOTICE SENT TO IB—
May 19, 2025FIMPFINAL DISPOSITION PROCESSED—
Mar 17, 2025FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Dec 17, 2024NRCCNOTICE OF REGISTRATION CONFIRMATION EMAILED—
Dec 17, 2024R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Nov 22, 2024TMBNTTAB RELEASE CASE TO TRADEMARKS—
Nov 22, 2024OP.TOPPOSITION TERMINATED NO. 999999—
Nov 22, 2024OP.SOPPOSITION SUSTAINED NO. 999999—
Sep 20, 2024RFNPREFUSAL PROCESSED BY IB—
Aug 23, 2024OP.IOPPOSITION INSTITUTED NO. 999999—
Aug 22, 2024OPNSOPPOSITION NOTICE (IB REFUSAL) SENT TO IB—
Aug 22, 2024OPNCOPPOSITION NOTICE (IB REFUSAL) CREATED—
Aug 21, 2024OPPFOPPOSITION PAPERS RECEIVED AT TTAB—
Aug 20, 2024NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Aug 20, 2024PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jul 31, 2024NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Jul 12, 2024CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jul 9, 2024XAECEXAMINER'S AMENDMENT ENTERED—
Jul 9, 2024ALIEASSIGNED TO LIE—
Jul 3, 2024GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Jul 3, 2024GNEAEXAMINERS AMENDMENT E-MAILED—
Jul 3, 2024CNEAEXAMINERS AMENDMENT -WRITTEN—
Jan 22, 2024RFNPREFUSAL PROCESSED BY IB—
Dec 25, 2023OPNXNOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB—
Dec 15, 2023GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Dec 15, 2023GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Dec 15, 2023CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Dec 8, 2023ZZZXPREVIOUS ALLOWANCE COUNT WITHDRAWN—
Dec 6, 2023OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Dec 6, 2023OPNRNOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB—
Nov 7, 2023PBCRWITHDRAWN FROM PUB - OG REVIEW QUERY—
Oct 26, 2023CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Sep 26, 2023TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Sep 25, 2023CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Sep 25, 2023TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Apr 13, 2023RFNTREFUSAL PROCESSED BY IB—
Mar 23, 2023RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Mar 23, 2023RFRRREFUSAL PROCESSED BY MPU—
Jan 28, 2023RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Jan 27, 2023CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jan 19, 2023DOCKASSIGNED TO EXAMINER—
Jul 5, 2022MAFRAPPLICATION FILING RECEIPT MAILED—
Jul 1, 2022NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Jun 30, 2022REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance